The Rheumatology Division at the University of Colorado has numerous ongoing clinical research studies. Our human research studies are divided into two main areas:
1) Treatment trials which involve the use of new therapies for disease
2) Studies on the development and prevention of diseases such as rheumatoid arthritis and lupus
Currently enrolling:
- Complement Receptor 2 as a Biomarker for Systemic Lupus Erythematosus
- Role of Complement Receptor 2 in systemic lupus Erthymatosus
For more information on any of our studies, please try the following links:
|
- Rheumatoid arthritis
- Psoriatic arthritis
- Lupus
- Other rheumatologic disease
|
|
|
- Sera Study
- SERA is identifying established and new, potentially important blood and genetic markers.
- SERA is looking for the presence of various autoantibodies* in the blood of healthy people. These autoantibodies may be present before physical symptoms of the disease are evident.
- SERA is also looking at possible environmental factors that could contribute to RA.
- SERA’s findings may lead to earlier diagnosis, and possible prevention of RA in the future.
|
|
|
|